Structure and function of uridine diphosphate glucuronosyltransferases

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 12, 1997, Pages 907-915

  Meech, Robyn ^a   Mackenzie, Peter I ^a,b  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Endoplasmic reticulum residence; Functional domains; Glucuronidation; Topology; Uridine diphosphate glucuronosyltransferase

Indexed keywords

GLUCURONOSYLTRANSFERASE; ISOENZYME; URIDINE DIPHOSPHATE GLUCURONIC ACID;

BINDING SITE; CYTOCHEMISTRY; DRUG TRANSPORT; ENDOPLASMIC RETICULUM; ENZYME ANALYSIS; ENZYME STRUCTURE; HUMAN; HYPERBILIRUBINEMIA; PROTEIN DOMAIN; REVIEW;

EID: 0030778114     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb02718.x     Document Type: Review

References (78)

1. Dutton GJ. Glucuronidation of drugs and other compounds. CRC Press, Boca Raton. 1980.
2. Tephly TR, Burchell B. UDP-glucuronosyltransferases: A family of detoxifying enzymes. Trends Pharmacol. Sci. 1990; 11: 276-9.
3. Mulder GJ. Glucuronidation and its role in regulation of biological activity of drugs. Annu. Rev. Pharmacol. Toxicol. 1992; 32: 25-49.
4. Williams AM, Worrel S, De Jersey J, Dickinson RG. Studies on the reactivity of acyl glucuronides III. Mol. Pharmacol. 1992; 43: 745-55.
5. Wilson R, Ainscough R, Anderson K et al. 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature 1994; 368: 32-8.
6. Mackenzie PI. The UDP glucuronosyltransferase multigene family. Rev. Biochem. Toxicol. 1995; 11: 29-72.
7. Lazard D, Zupko K, Poria Y et al. Odorant signal termination by olfactory UDP-glucuronosyltransferase. Nature 1991; 349: 790-3.
8. Burchell BB, Nebert DW, Nelson DR et al. The UDP glucuronosyl-transferase gene family. Suggested nomenclature based on evolutionary divergence. DNA Cell Biol. 1991; 10: 487-94.
9. Ritter JK, Chen F, Sheen YY et al. A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J. Biol. Chem. 1992; 267: 3257-61.
10. Emi Y, Ikushiro S, Iyanagi T. Drug-responsive and tissue-specific alternative expression of multiple first exons in rat UDP-glucuronosyltransferase family 1 (UGT1) gene complex. J. Biochem. 1995; 117: 392-9.
11. Ritter JK, Crawford JM, Owens IS. Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells. J. Biol. Chem. 1991; 266: 1043-7.
12. Mojarrabi B, Butler R, Mackenzie PI. cDNA cloning and characterisation of the human UDP-glucuronosyltransferase, UGT1 A3. Biochem. Biophys. Res. Commun. 1996; 225: 785-90.
13. Harding D, Fournel Gigleux S, Jackson M et al. Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells. Proc. Natl Acad. Sci. USA 1988; 85: 8381-5.
14. Wooster R, Sutherland L, Ebner T et al. Cloning and stable expression of a new member of the human liver phenol/bilirubin: UDP-glucuronosyltransferase cDNA family. Biochem. J. 1991; 278: 465-9.
15. Iyanagi T. Molecular basis of multiple UDP-glucuronosyltransferase isoenzyme deficiencies in the hyperbilirubinemic rat (Gunn rat). J. Biol. Chem. 1991; 266: 24048-52.
16. Sato H, Koiwai O, Tanabe K, Kashiwamata S. Isolation and sequencing of rat liver bilirubin UDP-glucuronosyltransferase cDNA: Possible alternate splicing of a common primary transcript. Biochem. Biophys. Res. Commun. 1990; 169: 260-4.
17. Iyanagi T, Haniu M, Sogawa K et al. Cloning and characterization of cDNA encoding 3-methylcholanthrene inducible rat mRNA for UDP-glucuronosyltransferase. J. Biol. Chem. 1986; 261: 15607-14.
18. Grove AD, Kessler FK, Metz RP, Ritter JK. Identification of a rat oltipraz-inducible UDP-glucuronosyltransferase (UGT1A7) with activity towards benzo(a)pyrene-7,8-dihydrodiol. J. Biol. Chem. 1997; 272: 1621-7.
19. Crigler JF, Najjar VA. Congenital familial non-hemolytic jaundice with kernicterus. Pediatrics 1952; 10: 169-80.
20. Aono S, Yamada Y, Keino H et al. A new type of defect in the gene for bilirubin UDP-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type I. Pediatr. Res. 1994; 35: 629-32.
21. Bosma PJ, Chowdhury NR, Goldhoorn BG et al. Sequence of exons and the flanking regions of human bilirubin UDP-glucuronosyltransferase gene complex and identification of a genetic mutation in a patient with Crigler-Najjar syndrome, type I. Hepatology 1992; 15: 941-7.
22. Seppen J, Bosma PJ, Goldhorn BG et al. Discrimination between Crigler-Najjar type I and II by expression of bilirubin uridine diphosphate-glucuronosyltransferase. J. Clin. Invest. 1994; 94: 2385-91.
23. Labrune PH, Myara A, Hadchouel M et al. Genetic heterogeneity of Crigler-Najjar syndrome type 1: A study of 14 cases. Hum. Genet. 1994; 94: 693-7.
24. Ciotti M, Obaray R, Martin MG, Owens IS. Genetic defects at the UGT1 locus associated with Crigler-Najjar type I disease: Including a prenatal diagnosis. Am. J. Med. Genet. 1996; 68: 173-8.
25. Moghrahi N, Clarke DJ, Burchell B, Boxer M. Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome Type 1: Implications in carrier detection and prenatal diagnosis. Am. J. Hum. Genet. 1993; 53: 722-9.
26. Ciotti M, Yeatman MT, Sokol RJ, Owens IS. Altered coding for a strictly conserved di-glycine in the major bilirubin UDP-glucuronosyltransferase of a Crigler-Najjar type I patient. J. Biol. Chem. 1996; 270: 3284-91.
27. Erps LT, Ritter JK, Hersch JH et al. Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro. J. Clin. Invest. 1994; 93: 564-70.
28. Bosma PJ, Chowdhury JR, Huang T et al. Mechanism of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type 1. FASEB J. 1992; 6: 2859-63.
29. Aono S, Yamada Y, Keino H et al. Identification of defect in the genes for bilirubin UDP-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type 2. Biochem. Biophys. Res. Commun. 1993; 197: 1239-44.
30. Bosma PJ, Goldhoorn BG, Oude Elferink PJ et al. A mutation in bilirubin UDP-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome, type II. Gastroenteralogy 1993; 105: 216-20.
31. Moghrabi N, Clarke DJ, Boxer M, Burchell. B. Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2. Genomics 1993; 18: 171-3.
32. Seppen J, Steenken E, Lindhout D et al. A mutation which disrupts the hydrophohic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II. FEBS Lett. 1996; 390: 294-8.
33. Black M, Billing BH. Hepatic bilirubin UDP-glucuronyl transferase activity in liver disease and Gilbert's disease. N. Engl. J. Med. 1969; 280: 1266-71.
34. Koiwai O, Nishizawa M, Hasada K et al. Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase. Hum. Mol. Genet. 1995; 4: 1183-6.
35. Bosma PJ, Chowdhury JR, Bakker C et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N. Engl. J. Med. 1995; 333: 1171-5.
36. Monaghan G, Ryan M, Seddon R et al. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996; 347: 578-81.
37. Monaghan G, Clarke DJ, Povey S et al. Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13. Genomics 1994; 23: 496-9.
38. Krasnewich D, Kozak CA, Nebert DW, Mackenzie PI. Localization of UDP glucuronosyltransferase genes on mouse chromosome 5. Som. Cell. Mol. Genet. 1987; 13: 179-82.
39. Philipp T, Durazzo M, Trautwein C et al. Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Lancet 1994; 344: 578-81.
40. Mackenzie PI, Owens IS. Cleavage of nascent UDP-glucuronosyltransferase from rat liver by pancreatic microsomes. Biochem. J. 1984; 122: 1441-9.
41. Mackenzie PI, Gonzalez FJ, Owens IS. Cell free translation of mouse liver mRNA coding for two forms of UDP glucuronosyltransferase. Arch. Biochem. Biophys. 1984; 230: 678-80.
42. Mackenzie PI. The effect of N-linked glycosylation on the substrate preferences of UDP glucuronosyltransferases. Biochem. Biophys. Res. Commun. 1990; 166: 1293-9.
43. Rost B, Sanders C. The jury returns on structure prediction. Nature 1993; 360: 540.
44. Koiwai O, Aono S, Adachi Y et al. Crigler-Najjar syndrome type II inherited as both a dominant and as a recessive trait. Hum. Mol. Genet. 1996; 5: 645-7.
45. Mackenzie PI. Expression of chimeric cDNAs in cell culture defines a region of UDP glucuronosyltransferase involved in substrate selection. J. Biol. Chem. 1990; 265: 3432-5.
46. King CD, Rios GR, Green MD, Mackenzie PI, Tephly TR. Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds. Drug Metab. Disp. 1997; 25: 251-5.
47. Coffman BL, Rios GR, King CD, Tephly TR. Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab. Disp. 1997; 25: 1-4.
48. Mackenzie PI. Structure and regulation of UDP-glucuronosyltransferases. In: Ruckpaul K, Rein H (eds). Frontiers in Biotransformation, Vol. 2. Principles, mechanisms and biological consequences of induction. K. Academie-Verlag, Berlin. 1990; 211-43.
49. Radominska A, Paul P, Treat S et al. Photoaffinity labeling for evaluation of uridinyl analogs as specific inhibitors of rat liver microsomal UDP-glucuronosyltransferases. Biochim. Biophys. Acta 1994; 1205: 336-45.
50. Battaglia E, Pritchard M, Ouzzine M et al. Chemical modification of human UDP-glucuronosyltransferase UGT1*6 by diethyl pyrocarbonate: Possible involvement of a histidine group in the catalytic process. Arch. Biochem. Biophys. 1994; 309: 266-72.
51. Pillot T, Ouzzine M, Fournel-Gigleux S et al. Determination of the human liver UDP-glucuronosyltransferase 2B4 domains involved in the binding of UDP-glucuronic acid using photoaffinity labelling of fusion proteins. Biochem. Biophys. Res. Commun. 1993; 197: 785-91.
52. Senay C, Ouzzine M, Battaglia E et al. Arginine 52 and histidine 54 located in a conserved amino-terminal hydrophobic region (LX2-R52-G-H54-X3-V-L) are important amino acids for the functional and structural integrity of the human liver UDP glucuronosyltransferase UGT1*6. Mol. Pharmacol. 1997; 51: 406-13.
53. Davies G, Henrissat B. Structures and mechanisms of glycosyl hydrolases. Structure 1995; 3: 853-9.
54. Fry DJ, Wishart GJ. Apparent induction by phenobarbital of uridine diphosphate glucuronosyltransferase activity in nuclear envelopes of embryonic-chick liver. Biochem. Soc. Trans. 1976; 4: 265-6.
55. Hauser SC, Ziurys JC, Gollan JL. Subcellular distribution and regulation of hepatic bilirubin UDP-glucuronosyltransferase. J. Biol. Chem. 1984; 259: 4527-33.
56. Jackson MR, Nilsson T, Peterson PA. Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J. 1990; 9: 3153-62.
57. Cosson P, Letourneur F. Coatomer interaction with di-lysine endoplasmic reticulum retention motifs. Science 1994; 263: 1629-31.
58. Kinosaki M, Masuko T, Sogawa K et al. Intracellular localisation of UDP-glucuronosyltransferase expressed from the transfected cDNA in cultured cells. Cell Struct. Funct. 1993; 18: 41-51.
59. Magdalou J, Hochman Y, Zakim D. Factors modulating the catalytic activity of a pure form of UDP glucuronosyltransferase. J. Biol. Chem. 1982; 257: 13 624-9.
60. Pillot T, Ouzzine M, Fournel-Gigleux S et al. Purification and characterization of a catalytically active human liver UDP-glucuronosyltransferase expressed as a fusion protein in E. coli. Biochem. Biophys. Res. Commun. 1993; 196: 473-9.
61. Sanchezpozzi EJ, Catania VA, Rodriguezgaray EA, Mottino AD. Enhancement of intestinal bilirubin UDP-glucuronosyltransferase activity by modification of microsomal lipid composition. Biochim. Biophys. Acta 1995; 1245: 293-8.
62. Toghrol F, Kimura T, Owens IS. Expression of UDP-glucuronosyltransferase cDNA in Saccharomyces cerevisiae as a membrane bound and cytosolic form. Biochemistry 1990; 29: 2349-56.
63. Fournel-Gigleux S, Ouzzine M, Battaglia E et al. Membrane topology and organization of human UDP-glucuronosyltransferase. In: Proceedings of the VIIIth International Workshop on Glucuronidation and the UDP-Glucuronosyltransferases. 1996.
64. Banhegyi G, Garzo T, Fuleri R et al. Latency is the major determinant of UDP-glucuronosyltransferase activity in isolated hepatocytes. FEBS Lett. 1993; 328: 149-52.
65. Bock KW, Lilienblum W. Roles of UDP-glucuronosyltransferases (UGTs) in chemical carcinogenesis. In: Kauffman FC (ed.). Handbook of experimental pharmacology, Vol. 112. Conjugation/deconjugation reactions in drug metabolism and toxicity. Springer Verlag, Berlin. 1994; 391-428.
66. Zakim D, Dannenberg AJ. How does the microsomal membrane regulate UDP-glucuronosyltransferases? Biochem. Pharmacol. 1992; 43: 1385-93.
67. Jansen PLM, Mulder GJ, Burchell B, Bock KW. New developments in glucuronidation research: Report of workshop on 'glucuronidation, its role in health and disease' Hepatology. 1992; 15: 532-44.
68. Yokota H, Yuasa A, Sata R. Topological disposition of UDP glucuronosyltransferase in rat liver microsomes. J. Biochem. 1992; 112: 192-6.
69. Meech R, Yogalingam G, Mackenzie PI. Mutational analysis of the carboxy-terminal region of UDP-glucuronosyltransferase 2B1. DNA Cell Biol. 1996; 15: 489-94.
70. Stremmel W, Diede HE. Cellular uptake of conjugated bilirubin and sulphobromophthalein (BSP) by the human hepatoma cell line Hep G2 is mediated by a membrane BSP/bilirubin binding protein. J. Hepatol. 1990; 10: 99-104.
71. Hauser SC, Ziurys JC, Gollan JL. A membrane transporter mediates access of uridine 5-diphosphoglucuronic acid from the cytosol into the endoplasmic reticulum of rat hepatocytes: Implication for glucuronidation reactions. Biochim. Biophys. Acta 1988; 267: 149-57.
72. Radominska A, Treat S, Little JM et al. Characterization of UDP-glucuronic acid transport in rat liver microsomal vesicles with photoaffinity analogues. Biochim. Biophys. Acta 1994; 1195: 63-70.
73. Hauser SC, Ransil BJ, Ziurys JC, Gollan JL. Interaction of uridine 5-diphosphoglucuronic acid with microsomal UDP-glucuronosyltransferase in primate liver: The facilitating role of uridine 5-diphospho-N-acetylglucosamine. Biochim. Biophys. Acta 1988; 267: 141-8.
74. Bossuyt X, Blanckaert N. Carrier-mediated transport of uridine diphosphoglucuronic acid across the endoplasmic reticulum membrane is a prerequisite for UDP-glucuronosyltransferase activity in rat liver. Biochem. J. 1997; 323: 645-8.
75. Banhegyi G, Braun L, Marcolongo P et al. Evidence for an UDP-glucuronic acid phenol glucuronide antiport in rat liver microsomal vesicles. Biochem. J. 1996; 315: 171-6.
76. Crawford JM, Gollan JL. Hepatocyte cotransport of taurocholate and bilirubin glucuronides: Role of microtubules. Am. J. Physiol. 1988; 255: G121-31.
77. Paulusma CC, Bosma PJ, Zaman GJR et al. Congenital jaundice in rats with a mutation in a multidrug-resistance-associated protein gene. Science 1996; 271: 1126-8.
78. Bosio A, Binczek E, Le Beau MM et al. The human gene encoding the UDP-galactose galactosyl transferase (cerebroside synthase): Cloning, characterization and assignment to human chromosome 4, band q26. Genomics 1996; 34: 69-75.